140 related articles for article (PubMed ID: 17003742)
21. Long-term clinical outcomes following resectoscopic endometrial ablation of non-atypical endometrial hyperplasia in women with abnormal uterine bleeding.
Vilos GA; Oraif A; Vilos AG; Ettler H; Edris F; Abu-Rafea B
J Minim Invasive Gynecol; 2015 Jan; 22(1):66-77. PubMed ID: 25048567
[TBL] [Abstract][Full Text] [Related]
22. [Diagnostic accuracy in transvaginal echography in benign endometrial diseases and its comparison with hysteroscopic biopsy].
Persiani P; Perotti F; Riccardi A; Gallina D; Polatti F; Zara C
Minerva Ginecol; 1995 Mar; 47(3):63-7. PubMed ID: 7630511
[TBL] [Abstract][Full Text] [Related]
23. Pre-operative endometrial thinning agents before hysteroscopic surgery for heavy menstrual bleeding.
Sowter MC; Singla AA; Lethaby A
Cochrane Database Syst Rev; 2000; (2):CD001124. PubMed ID: 10796747
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of hyperplasias of the endometrium].
Favreau JJ
Rev Fr Gynecol Obstet; 1987 May; 82(5):351-4. PubMed ID: 3602811
[TBL] [Abstract][Full Text] [Related]
25. Resectoscopic surgery may be an alternative to hysterectomy in high-risk women with atypical endometrial hyperplasia.
Edris F; Vilos GA; Al-Mubarak A; Ettler HC; Hollett-Caines J; Abu-Rafea B
J Minim Invasive Gynecol; 2007; 14(1):68-73. PubMed ID: 17218233
[TBL] [Abstract][Full Text] [Related]
26. Transvaginal ultrasonography and endometrial cytology as a diagnostic schema for endometrial cancer.
Minagawa Y; Sato S; Ito M; Onohara Y; Nakamoto S; Kigawa J
Gynecol Obstet Invest; 2005; 59(3):149-54. PubMed ID: 15637434
[TBL] [Abstract][Full Text] [Related]
27. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
Varma R; Soneja H; Bhatia K; Ganesan R; Rollason T; Clark TJ; Gupta JK
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
[TBL] [Abstract][Full Text] [Related]
28. [Endometrial hyperplasia, diagnosis. Clinical, paraclinical exam and management].
Pangal A; Costăchescu G; Aldea MJ
Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):445-9. PubMed ID: 20700983
[TBL] [Abstract][Full Text] [Related]
29. Ultrasound assessment of endometrial cavity in perimenopausal women on oral progesterone for abnormal uterine bleeding: comparison of diagnostic accuracy of imaging with hysteroscopy-guided biopsy.
Dasgupta S; Dasgupta S; Sharma PP; Mukherjee A; Ghosh TK
J Obstet Gynaecol Res; 2011 Nov; 37(11):1575-81. PubMed ID: 21733032
[TBL] [Abstract][Full Text] [Related]
30. Resectoscopic surgery in 10 women with abnormal uterine bleeding and atypical endometrial hyperplasia.
Vilos GA; Harding PG; Ettler HC
J Am Assoc Gynecol Laparosc; 2002 May; 9(2):138-44. PubMed ID: 11960037
[TBL] [Abstract][Full Text] [Related]
31. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
Tan YH; Lethaby A
Cochrane Database Syst Rev; 2013 Nov; (11):CD010241. PubMed ID: 24234875
[TBL] [Abstract][Full Text] [Related]
32. Fertility-Sparing Treatment of Early Endometrial Cancer and Complex Atypical Hyperplasia in Young Women of Childbearing Potential.
Pronin SM; Novikova OV; Andreeva JY; Novikova EG
Int J Gynecol Cancer; 2015 Jul; 25(6):1010-4. PubMed ID: 25950126
[TBL] [Abstract][Full Text] [Related]
33. Regression of endometrial hyperplasia after treatment with the gonadotrophin-releasing hormone analogue triptorelin: a prospective study.
Grimbizis G; Tsalikis T; Tzioufa V; Kasapis M; Mantalenakis S
Hum Reprod; 1999 Feb; 14(2):479-84. PubMed ID: 10099998
[TBL] [Abstract][Full Text] [Related]
34. The management of endometrial hyperplasia: an evaluation of current practice.
Clark TJ; Neelakantan D; Gupta JK
Eur J Obstet Gynecol Reprod Biol; 2006 Apr; 125(2):259-64. PubMed ID: 16246481
[TBL] [Abstract][Full Text] [Related]
35. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy.
Bourdrez P; Bongers MY; Mol BW
Fertil Steril; 2004 Jul; 82(1):160-6, quiz 265. PubMed ID: 15237006
[TBL] [Abstract][Full Text] [Related]
36. Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up.
Gallos ID; Krishan P; Shehmar M; Ganesan R; Gupta JK
Hum Reprod; 2013 May; 28(5):1231-6. PubMed ID: 23466671
[TBL] [Abstract][Full Text] [Related]
37. [An analysis on the clinicopathological characteristics of 79 cases atypical endometrial hyperplasia].
Wang ZQ; Yang XQ; Wang JL; Xie JL; Shen DH; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):19-23. PubMed ID: 21429429
[TBL] [Abstract][Full Text] [Related]
38. Abnormal uterine bleeding in perimenopause.
Goldstein SR; Lumsden MA
Climacteric; 2017 Oct; 20(5):414-420. PubMed ID: 28780893
[TBL] [Abstract][Full Text] [Related]
39. Treatment of endometrial hyperplasias with gonadotropin-releasing hormone agonists: pathological, clinical, morphometric, and DNA-cytometric data.
Agorastos T; Bontis J; Vakiani A; Vavilis D; Constantinidis T
Gynecol Oncol; 1997 Apr; 65(1):102-14. PubMed ID: 9103399
[TBL] [Abstract][Full Text] [Related]
40. [Surgical hysteroscopy or hysterectomy in the treatment of benign uterine lesions. What to choose in 1998?].
Herman P; Gaspard U; Foidart JM
Rev Med Liege; 1998 Dec; 53(12):756-61. PubMed ID: 9927874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
